EKSO — Ekso Bionics Holdings Balance Sheet
0.000.00%
- $13.62m
- $12.23m
- $17.93m
- 37
- 57
- 22
- 32
Annual balance sheet for Ekso Bionics Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 12.9 | 40.4 | 20.5 | 8.64 | 6.49 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 3.39 | 4.66 | 4.63 | 5.64 | 7.24 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 18.4 | 47.8 | 31 | 20.2 | 18.8 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1.86 | 1.21 | 3.99 | 3 | 2.37 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 20.6 | 49.2 | 40.9 | 28.9 | 26.7 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4.97 | 6.86 | 9.2 | 8.12 | 7.54 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 16.2 | 11.9 | 15.5 | 16.3 | 13.9 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 4.43 | 37.2 | 25.4 | 12.6 | 12.7 |
Total Liabilities & Shareholders' Equity | 20.6 | 49.2 | 40.9 | 28.9 | 26.7 |
Total Common Shares Outstanding |